IL77052A - Hexafluoro-1alpha,25-dihydroxy-cholecalciferol derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Hexafluoro-1alpha,25-dihydroxy-cholecalciferol derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL77052A
IL77052A IL77052A IL7705285A IL77052A IL 77052 A IL77052 A IL 77052A IL 77052 A IL77052 A IL 77052A IL 7705285 A IL7705285 A IL 7705285A IL 77052 A IL77052 A IL 77052A
Authority
IL
Israel
Prior art keywords
1alpha
hexafluoro
dihydroxy
preparation
pharmaceutical compositions
Prior art date
Application number
IL77052A
Other languages
English (en)
Other versions
IL77052A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL77052A0 publication Critical patent/IL77052A0/xx
Publication of IL77052A publication Critical patent/IL77052A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C7/00—Purification; Separation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/44—Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Water Supply & Treatment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL77052A 1984-11-16 1985-11-14 Hexafluoro-1alpha,25-dihydroxy-cholecalciferol derivatives,their preparation and pharmaceutical compositions containing them IL77052A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/672,059 US4613594A (en) 1984-11-16 1984-11-16 Fluorinated vitamin D3 compounds

Publications (2)

Publication Number Publication Date
IL77052A0 IL77052A0 (en) 1986-04-29
IL77052A true IL77052A (en) 1990-02-09

Family

ID=24696990

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77052A IL77052A (en) 1984-11-16 1985-11-14 Hexafluoro-1alpha,25-dihydroxy-cholecalciferol derivatives,their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US4613594A (fr)
EP (1) EP0182298B1 (fr)
JP (1) JPS61122237A (fr)
KR (1) KR930007993B1 (fr)
AR (1) AR242767A1 (fr)
AT (1) ATE48412T1 (fr)
AU (1) AU588012B2 (fr)
CA (1) CA1286693C (fr)
DE (1) DE3574587D1 (fr)
DK (1) DK159652C (fr)
ES (1) ES8801198A1 (fr)
FI (1) FI84599C (fr)
HU (1) HU194162B (fr)
IE (1) IE58851B1 (fr)
IL (1) IL77052A (fr)
MC (1) MC1709A1 (fr)
NO (1) NO162906C (fr)
NZ (1) NZ214175A (fr)
PH (1) PH21540A (fr)
PT (1) PT81502B (fr)
ZA (1) ZA858151B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63196556A (ja) * 1987-02-10 1988-08-15 Taisho Pharmaceut Co Ltd 含フツ素ビタミンｄ誘導体
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
AU5185790A (en) * 1989-02-16 1990-09-05 University Of Georgia Research Foundation, Inc., The Treatment of tibial dyschondroplasia
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5278155A (en) * 1991-06-05 1994-01-11 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and cell differentiation-inducing agent containing the same
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
EP0521550B1 (fr) * 1991-07-05 1996-09-18 Duphar International Research B.V Dérivé de vitamine D, procédé de préparation et intermédiaires de ce procédé
CA2096105A1 (fr) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Analogues fluores de vitamine d3
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
AU2005303773A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
JPS57149224A (en) * 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4358406A (en) * 1981-07-27 1982-11-09 Wisconsin Alumni Research Foundation 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
DE3471928D1 (en) * 1983-01-28 1988-07-14 Hoffmann La Roche Process for the preparation of cholecalciferol derivatives
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters

Also Published As

Publication number Publication date
KR860004073A (ko) 1986-06-16
FI854492A (fi) 1986-05-17
ZA858151B (en) 1986-06-25
DK159652C (da) 1991-04-08
CA1286693C (fr) 1991-07-23
DK524585D0 (da) 1985-11-13
ES548910A0 (es) 1987-12-16
FI854492A0 (fi) 1985-11-14
NO162906C (no) 1990-03-07
DE3574587D1 (de) 1990-01-11
DK159652B (da) 1990-11-12
PT81502B (pt) 1988-03-03
PH21540A (en) 1987-11-16
PT81502A (en) 1985-12-01
NO854576L (no) 1986-05-20
AR242767A1 (es) 1993-05-31
US4613594A (en) 1986-09-23
EP0182298B1 (fr) 1989-12-06
HUT39138A (en) 1986-08-28
JPH051770B2 (fr) 1993-01-11
FI84599C (fi) 1991-12-27
NZ214175A (en) 1989-04-26
EP0182298A1 (fr) 1986-05-28
IL77052A0 (en) 1986-04-29
DK524585A (da) 1986-05-17
IE58851B1 (en) 1993-11-17
FI84599B (fi) 1991-09-13
ES8801198A1 (es) 1987-12-16
IE852875L (en) 1986-05-16
ATE48412T1 (de) 1989-12-15
KR930007993B1 (ko) 1993-08-25
AU5089885A (en) 1986-05-29
HU194162B (en) 1988-01-28
MC1709A1 (fr) 1986-09-22
JPS61122237A (ja) 1986-06-10
AU588012B2 (en) 1989-09-07
NO162906B (no) 1989-11-27

Similar Documents

Publication Publication Date Title
IL76453A (en) Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL77004A0 (en) 5-amino-4-hydroxyvaleryl derivatives,their manufacture and pharmaceutical compositions containing them
IL75197A0 (en) Aminotetralin derivatives,their preparation and pharmaceutical compositions containing them
IL76405A0 (en) 1,3-diacyl-2-oxyindole derivatives,their preparation and pharmaceutical compositions containing them
IL70756A0 (en) 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL72151A0 (en) Tetrahydropyridazinone derivatives,their preparation and pharmaceutical compositions containing them
IL77052A (en) Hexafluoro-1alpha,25-dihydroxy-cholecalciferol derivatives,their preparation and pharmaceutical compositions containing them
IL70755A (en) 3-amino-4-cyano-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL76546A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
ZA853667B (en) New benzazephine derivatives,pharmaceutical compositions containing them and processes for their preparation
IL75966A0 (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
IL75720A0 (en) Morpholinol compounds,their preparation and pharmaceutical compositions containing them
IL74803A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
EP0159652A3 (en) 4-phenylphthalazine derivatives, their preparation and pharmaceutical compositions containing them
IL76312A (en) Xenocoumacins and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3573428D1 (en) Novel delta4- and delta5- androstene derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives
DE3561808D1 (en) Phenylnonatetraenic-acid derivatives, their preparation and pharmaceutical compositions containing them
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
IL75775A0 (en) Aminoeburnanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75776A0 (en) Nitroapovincaminic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3570667D1 (en) 3-aminopropyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL76041A0 (en) Aminoalkylpenem derivatives,their preparation and pharmaceutical compositions containing them
IL74776A0 (en) Eburnane derivatives,their preparation and pharmaceutical compositions containing them
IL74881A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL77230A (en) Aminomethyl-oxooxazolidinylbenzene derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void